Using AI Chatbots to Help Diabetic Patients
Exploring the Effectiveness of AI Generative Models for Diabetic Patients
This study tests whether AI chatbots can help people with diabetes by giving them useful information on diet, stress management, and weight control, and compares their experiences with and without human support.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Pakistan Council of Scientific and Industrial Research Academic / other |
| Locations | 1 site (Karachi, Sindh) |
| Trial ID | NCT05883072 on ClinicalTrials.gov |
What this trial studies
This study explores the effectiveness of generative AI chatbots in assisting diabetic patients by providing them with accurate information on diet, stress management, and weight control. With diabetes affecting millions globally and leading to serious complications, the research aims to evaluate patient interactions with AI chatbots, both with and without human support. Specialists will assess these interactions, and patient feedback will be collected to understand their experiences and perceptions of the chatbot assistance.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are diabetic and currently residing in Pakistan.
Not a fit: Patients who are unable to consent or are not adults, such as infants, children, and teenagers, will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could empower diabetic patients with better management tools and information, potentially reducing complications associated with diabetes.
How similar studies have performed: While the use of AI chatbots in healthcare is a growing field, this specific application for diabetic patients is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Present physically in Pakistan * Adults (18 years or older) * Diabetic Patient Exclusion Criteria: * Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) * Prisoners
Where this trial is running
Karachi, Sindh
- CDLE, PCSIR Lbas Complex — Karachi, Sindh, Pakistan (Recruiting)
Study contacts
- Principal investigator: Ghulam Mustafa — Pakistan Council of Scientific and Industrial Research
- Study coordinator: Ghulam Mustafa
- Email: mustafabme@gmail.com
- Phone: +923322340395
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.